A Clinical Study of Nemtabrutinib in Japanese Participants With Hematological Malignancies (MK-1026-002)
Status:
Not yet recruiting
Trial end date:
2026-03-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and
preliminary efficacy of nemtabrutinib in Japanese participants with mature B-cell neoplasms.